AbbVie partners with Simcere Pharma unit to develop myeloma drug
AbbVie is teaming up with Simcere Zaiming to develop an investigational new drug candidate for multiple myeloma.
The agreement, announced Monday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
